title: FPIN's clinical inquiries. Risks of bisphosphonate use.
authors.affiliation: University of North Carolina Eshelman School of Pharmacy, Asheville , NC, USA.
authors.forename: Mollie Ashe
authors.initials: MA
authors.lastname: Scott
authors.affiliation: South Carolina College of Pharamcy, Charleston, SC, USA.
authors.forename: Lindsy
authors.initials: L
authors.lastname: Meadowcraft
authors.affiliation: Mountain Area Health Education Center, Asheville, NC, USA.
authors.forename: Debbie
authors.initials: D
authors.lastname: Skolnik
mesh_terms: D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000209:etiology* / Q000517:prevention & control; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005264:Femoral Fractures / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D059352:Musculoskeletal Pain / Q000139:chemically induced; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates